Related references
Note: Only part of the references are listed.Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer
Xiao-qin Wu et al.
CELLULAR SIGNALLING (2013)
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy
Marco Ruella et al.
EXPERIMENTAL HEMATOLOGY (2013)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen et al.
NATURE GENETICS (2013)
Identification of seven loci affecting mean telomere length and their association with disease
Veryan Codd et al.
NATURE GENETICS (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inherited predisposition to myeloproliferative neoplasms
Amy V. Jones et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Telomerase Reverse Transcriptase Locus Polymorphisms and Cancer Risk: A Field Synopsis and Meta-Analysis
Simone Mocellin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
A. Tefferi et al.
LEUKEMIA (2010)
Genome-wide association study of hematological and biochemical traits in a Japanese population
Yoichiro Kamatani et al.
NATURE GENETICS (2010)
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Outi Kilpivaara et al.
NATURE GENETICS (2009)
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Thorunn Rafnar et al.
NATURE GENETICS (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
Animesh Pardanani et al.
BLOOD (2008)
Share Paper
